Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in Relapsed and Refractory Non-Hodgkin's Lymphoma
NCT00006473Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2000
- Primary completion
- Feb 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in non-Hodgkin lymphoma (NHL), sponsored by National Cancer Institute. Started Sep 2000; status: completed.
02
Drugs
oxaliplatin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00006473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006473.